{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T06:12:00Z","timestamp":1780467120704,"version":"3.54.1"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,19]]},"DOI":"10.7759\/cureus.92741","type":"journal-article","created":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T00:26:08Z","timestamp":1758327968000},"source":"Crossref","is-referenced-by-count":1,"title":["Neurovisceral Syndrome in a Patient with Monoclonal Gammopathy of Undetermined Significance: A Confirmed Case of Variegate Porphyria"],"prefix":"10.7759","author":[{"given":"Iraj","family":"Fatima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kashaf ad Duja","family":"Awais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aasim","family":"Sehbai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Awais Khan","family":"Tareen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maheen","family":"Shaharyar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/ddg.14743","article-title":"The porphyrias","volume":"20","author":"Muschalek W","year":"2022","unstructured":"Muschalek W, Hermasch MA, Poblete-Guti\u00e9rrez P, Frank J. The porphyrias. J Dtsch Dermatol Ges. 2022, 20:316-31. 10.1111\/ddg.14743","journal-title":"J Dtsch Dermatol Ges"},{"key":"ref2","unstructured":"Orphanet. Variegate porphyria. (2021). Accessed. June 27, 2025: https:\/\/www.orpha.net\/en\/disease\/detail\/79473."},{"key":"ref3","article-title":"Variegate porphyria","author":"Singal AK","year":"2013","unstructured":"Singal AK, Anderson KE. Variegate porphyria. GeneReviews\u00ae. Adam MP, Feldman J, Mirzaa GM, et al. (ed): University of Washington, Seattle, WA; 2013."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-022-00661-1","article-title":"Cutaneous manifestations of monoclonal gammopathy","volume":"12","author":"Claveau JS","year":"2022","unstructured":"Claveau JS, Wetter DA, Kumar S. Cutaneous manifestations of monoclonal gammopathy. Blood Cancer J. 2022, 12:58. 10.1038\/s41408-022-00661-1","journal-title":"Blood Cancer J"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-04-839480","article-title":"Monoclonal gammopathy of clinical significance: a novel concept with therapeutic implications","volume":"132","author":"Fermand JP","year":"2018","unstructured":"Fermand JP, Bridoux F, Dispenzieri A, Jaccard A, Kyle RA, Leung N, Merlini G. Monoclonal gammopathy of clinical significance: a novel concept with therapeutic implications. Blood. 2018, 132:1478-85. 10.1182\/blood-2018-04-839480","journal-title":"Blood"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2147\/TACG.S48605","article-title":"An update of clinical management of acute intermittent porphyria","volume":"8","author":"Pischik E","year":"2015","unstructured":"Pischik E, Kauppinen R. An update of clinical management of acute intermittent porphyria. Appl Clin Genet. 2015, 8:201-14. 10.2147\/TACG.S48605","journal-title":"Appl Clin Genet"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.2174\/1871525718666200910162000","article-title":"Acute neurological manifestations of porphyrias and its types: a systematic- review","volume":"19","author":"Barletta EA","year":"2021","unstructured":"Barletta EA, Belsuzarri TA, Urena AR, Iunes EA. Acute neurological manifestations of porphyrias and its types: a systematic- review. Cardiovasc Hematol Agents Med Chem. 2021, 19:3-7. 10.2174\/1871525718666200910162000","journal-title":"Cardiovasc Hematol Agents Med Chem"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1080\/00365520410008395","article-title":"Variegate porphyria presenting with acute autonomic dysfunction, intussusception and renal infarction","volume":"39","author":"Griffith JC","year":"2004","unstructured":"Griffith JC, Jardine DL, Bailey W, Florkowski CM. Variegate porphyria presenting with acute autonomic dysfunction, intussusception and renal infarction. Scand J Gastroenterol. 2004, 39:500-3. 10.1080\/00365520410008395","journal-title":"Scand J Gastroenterol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2021.0586","article-title":"Update on the diagnosis and treatment of POEMS (polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes) syndrome: a review","volume":"7","author":"Khouri J","year":"2021","unstructured":"Khouri J, Nakashima M, Wong S. Update on the diagnosis and treatment of POEMS (polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes) syndrome: a review. JAMA Oncol. 2021, 7:1383-91. 10.1001\/jamaoncol.2021.0586","journal-title":"JAMA Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1045002","article-title":"Monoclonal gammopathies of clinical significance (MGCS): In pursuit of optimal treatment","volume":"13","author":"Oganesyan A","year":"2022","unstructured":"Oganesyan A, Gregory A, Malard F, et al.. Monoclonal gammopathies of clinical significance (MGCS): In pursuit of optimal treatment. Front Immunol. 2022, 13:1045002. 10.3389\/fimmu.2022.1045002","journal-title":"Front Immunol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1182\/hematology.2024000665","article-title":"Neurological manifestations of MGUS","volume":"2024","author":"Cibeira MT","year":"2024","unstructured":"Cibeira MT, Rodr\u00edguez-Lobato LG, Alejaldre A, Fern\u00e1ndez de Larrea C. Neurological manifestations of MGUS. Hematology Am Soc Hematol Educ Program. 2024, 2024:499-504. 10.1182\/hematology.2024000665","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1913147","article-title":"Phase 3 trial of RNAi therapeutic givosiran for acute intermittent porphyria","volume":"382","author":"Balwani M","year":"2020","unstructured":"Balwani M, Sardh E, Ventura P, et al.. Phase 3 trial of RNAi therapeutic givosiran for acute intermittent porphyria. N Engl J Med. 2020, 382:2289-301. 10.1056\/NEJMoa1913147","journal-title":"N Engl J Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-024-03284-w","article-title":"Long-term follow-up of givosiran treatment in patients with acute intermittent porphyria from a phase 1\/2, 48-month open-label extension study","volume":"19","author":"Sardh E","year":"2024","unstructured":"Sardh E, Balwani M, Rees DC, Anderson KE, Jia G, Sweetser MT, Wang B. Long-term follow-up of givosiran treatment in patients with acute intermittent porphyria from a phase 1\/2, 48-month open-label extension study. Orphanet J Rare Dis. 2024, 19:365. 10.1186\/s13023-024-03284-w","journal-title":"Orphanet J Rare Dis"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.06.013","article-title":"Efficacy and safety of givosiran for acute hepatic porphyria: Final results of the randomized phase III ENVISION trial","volume":"79","author":"Kuter DJ","year":"2023","unstructured":"Kuter DJ, Bonkovsky HL, Monroy S, et al.. Efficacy and safety of givosiran for acute hepatic porphyria: Final results of the randomized phase III ENVISION trial. J Hepatol. 2023, 79:1150-8. 10.1016\/j.jhep.2023.06.013","journal-title":"J Hepatol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s00105-015-3745-3","article-title":"Neurocutaneous porphyrias (in German)","volume":"67","author":"Frank J","year":"2016","unstructured":"Frank J. Neurocutaneous porphyrias (in German). Hautarzt. 2016, 67:221-5. 10.1007\/s00105-015-3745-3","journal-title":"Hautarzt"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/409707-neurovisceral-syndrome-in-a-patient-with-monoclonal-gammopathy-of-undetermined-significance-a-confirmed-case-of-variegate-porphyria","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T00:26:12Z","timestamp":1758327972000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/409707-neurovisceral-syndrome-in-a-patient-with-monoclonal-gammopathy-of-undetermined-significance-a-confirmed-case-of-variegate-porphyria"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,19]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.92741","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9,19]]}}}